NMRA

NASD Neumora Therapeutics, Inc.
Oct 17, 2026 · 10:18 AM ET EOD Market Closed

$0.4738 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.4738, $0.0324 below the day’s high of $0.5062

YTD change
-73.53%
vs 20-day SMA
-16.41%
vs 200-day SMA
-74.61%

Price ranges

Previous day
$0.4200 $0.5062
open $0.4366 close $0.4738
+$0.0372 (+8.52%)
Today
$0.4200 $0.5062
$0.4738
Past week
$0.3154 $0.5100
from $0.4798 now $0.4738
-$0.0060 (-1.25%)
Past month
$0.3154 $0.8111
from $0.7500 now $0.4738
-$0.2762 (-36.83%)
This year
$0.3154 $3.6500
from $1.7900 now $0.4738
-$1.3162 (-73.53%)

Price & Performance

-1.68 (-77.96%) / 6M

$0.1853$1.00$1.82$2.64Apr 17Jul 20Oct 16

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 97.7% away from all-time highs of $21.0000
  • NMRA is down 74% since the beginning of the year
  • NMRA is down 73% over the past 12 months
  • NMRA is down 37% over the past 1 month
  • 5% of all NMRA investors are betting against NMRA

NMRA reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is -72.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.23
Earnings momentum -16.3% Quarterly EPS growth
Quarterly change -16.3%

Valuation

P/E ratio N/A
Enterprise value $15.5M
Beta 2.97

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$116.8M
Debt$53.3K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $89.0M

Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. The firm offers a precision medicine approach for brain diseases through the integration of data science and neuroscience. It focuses on advancing medicines for therapeutically relevant targets implicated in CNS diseases, targeting novel mechanisms of action with best-in-class pharmacology. The company was founded by Paul L. Berns, Carol Suh and Mike Poole in November 2019 and is headquartered in Watertown, MA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,257.03 +0.43%
JNJ Johnson & Johnson $255.56 +0.90%
ABBV AbbVie, Inc. $285.42 +0.71%
MRK Merck & Co., Inc. $145.95 +0.52%
RHHVF Roche Holding Ltd $457.35 +0.07%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.